Parkinson’s disease (PD) is a chronic disease manifested principally by motor signs and symptoms, but with frequent neuropsychological alterations.ObjectivesTo study the relationship between clinical and cognitive aspects and the perception of quality of life (QOL) in PD patients.MethodsTwenty consecutive patients (13 men) with idiopathic PD (mean age: 64.5y), mean disease time of 7.8 years and at stages 1-3 according to the modified Hoehn and Yahr staging scale (HYS), all outpatients from the Neurology Department of the Celso Pierro General and Maternity Hospital (PUC-Campinas), were analyzed. The following were applied: a clinical-neurological assessment, the Mini-Mental State Examination (MMSE), standard neuropsychological battery of the CERAD (Consortium to Establish a Registry for Alzheimer’s Disease), Hamilton Depression Rating Scale (HAM-D) and a QOL questionnaire (Parkinson’s Disease Questionnaire - PDQ-39). Statistical analysis was carried out at a significance level of p<0.05.ResultsOn the PDQ-39 under the sections total, mobility and activities of daily living, and the items motor compromise (HYS) and language of the MMSE were predictors of worse QOL. Verbal fluency was a factor for emotional well-being on the PDQ-39, whereas higher scores for HAM-D and worse performance on the item attention and calculation of the MMSE were associated with worse QOL in the social support section. Total score on the MMSE and educational level were QOL factors in cognition.ConclusionsThe findings of the present study suggest that clinical, cognitive, motor or other depression-related factors contribute differently to the domains of QOL.
A principal complicação foi ruptura de cápsula posterior. Conclusão: Após toda a análise, verificamos que os fatores que implicaram com significância estatística em menor AV final foram as complicações intraoperatórias e a idade dos pacientes. Descritores: Cristalino; Catarata; Extração de catarata; Procedimentos cirúrgicos oftalmológicos; Facoemulsificação; Acuidade visual Objective: Compare visual acuity (VA) of patients after cataract surgery with and without intraoperative complications regarding possible factors that contributed to the outcome on postoperative follow-up. Methods: Longitudinal, retrospective study that evaluated 179 medical records of patients who underwent cataract surgery under the technique Phacoemulsification (PHACO) in the Suel Abujamra Institute from february to july 2013. Patients were divided into two groups concerning presence or absence of intraoperative complications. Data were analyzed using t-test methods for two samples or (ANOVA) Analysis of Variance. Exclusion criteria were: patients with previous ocular surgery, retinopathy related to diabetes, either proliferative or severe non proliferative, other retinopathies, optic disc cup equal to or greater than 0,7x0,7, use of more than two ocular hypotensive medications, only one eye, cataract due to uveitis, trauma or congenital. Results: 37 (20.7%) patients had intraoperative complications and 142 (79.3%) had not. Average age of patients was 70.33 years. There were 49.7% surgeries of the right eye and 50.3% of the left eye. There were 29.05% diabetic patients, of which 29.73% had intraoperative complications and 28.87% had not. From the 179 patients, 77.65% reached a final VA of 20/40 or better, considering that patients with intraoperative complications reached a VA of about 59.46% and patients without intraoperative complications of about 82.40%. The main complication was posterior capsular tear. Conclusion: After entire evaluation, we realized that factors that influenced lower final VA, with statistical significance, were intraoperative complications and patient age.
To evaluate the safety and 12-month effect of treatment with pattern scanning laser photocoagulation for ocular surface squamous neoplasia in a low-resource setting with extremely limited access to an operating room. Methods: Adult patients with a clinical diagnosis of ocular surface squamous neoplasia underwent a complete ophthalmologic examination. After topical anesthesia and instillation of toluidine blue 1%, the lesion was treated using pattern scanning photocoagulation for a duration time that varied from 20 to 100 ms and power from 600 to 1,800 mW. Patients were examined on a weekly basis for the first month and underwent weekly retreatment of the remaining lesions, as necessary. Patients had a minimum follow-up of 12 months. Results: Thirty-eight patients (38 eyes) were included. All patients had clinical ocular surface squamous neoplasia that was confirmed by impression cytology. The age of patients ranged from 40 to 83 years (average: 65.5 years) and 28 of them were males (74%). The patients were divided into two groups: group I (immunocompetent) and group II (immunosuppressed). In group I, 23 patients (74%) presented complete response with lesion control after laser treatment alone. In group II, two of seven patients (28%) showed treatment response during the follow-up. The average number of treatments was 2.5 (one to six laser treatments). Procedures were well tolerated. Conclusion: Short-term results of the laser photocoagulation approach for the treatment of ocular surface squamous neoplasia conjunctival lesions were favorable, with a 74% success rate observed in immunocompetent patients. This novel strategy is a less resource-intensive alternative that could demonstrate its usefulness in settings with shortages in operating rooms and in recurrent cases. Studies with longer follow-ups and larger sample sizes are warranted to confirm our findings and evaluate the effectiveness of laser treatment in association with topical chemotherapy.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.